MarketPeel
Pricing
…
EVP R&D, Chief Medical Officer
Craig C. Hopkinson
Fri, Nov 17, 2023
Nov 17
reported an acquisition in ALKS
2,790 shares @ $24.59
Increased holdings by +2.00%
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W-1.49%
1M-8.62%
3M—
6M—
1Y—

Recent insider activity at ALKS

Aug 17Christian Todd NicholsSold$32.97kAug 17Christian Todd NicholsSold$339.97kAug 3David Joseph GaffinSold$98.81kAug 3Nancy Lynn Md SnydermanSold$2.24mAug 3Craig C. HopkinsonSold$437.22kJul 6David Joseph GaffinSold$109.90kJul 1Craig C. HopkinsonSold$427.13kJul 1Craig C. HopkinsonSold$36.49k
Full ALKS profile →Craig C. Hopkinson’s trading history →
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback